Reduced circulating CD4+CD25+ cell populations in Guillain-Barré syndrome

J Neuroimmunol. 2007 Feb;183(1-2):232-8. doi: 10.1016/j.jneuroim.2006.12.002. Epub 2007 Jan 18.

Abstract

Guillain-Barré syndrome (GBS) is a monophasic inflammatory disease considered to be due to autoimmunity. In order to test the hypothesis that the disease is associated with a perturbation of the circulating lymphoid cell population, we tested the mononuclear cells from the venous blood of 21 patients with Guillain-Barré syndrome (GBS) and 20 healthy controls by flow cytometry. The proportions and numbers of B and T lymphocytes, and CD4, CD8, double negative and gammadelta T cell subsets and numbers of monocytes were not significantly different in the patients compared with the controls. However, the number and proportion of CD4+CD25+ cells were reduced in acute GBS (mean number 61.7 cells/microl, 95% CI 42.9-80.4 and mean percentage 4.6%, 95% CI 3.8-5.4) compared with controls (mean number 99.8 cells/microl, 95% CI 74.7-124.9, p=0.02, and mean percentage 6.0%, 95% CI 4.9-7.1%, p=0.037). In addition, in GBS patients, the number and proportion of CD4+ T cells expressing CD25+ and HLA-DP, DQ, DR (mean number 11.9 cells/microl, 95% CI 7.6-16.1 and mean percentage 0.8%, 95% CI 0.5-1.1%) was lower than in healthy controls (23.5 cells/microl, 95% CI 16.4-30.6, p=0.01, and mean percentage 1.4%, 95% CI 1.1-1.8%, p=0.005. Since CD4+CD25+ cells include cells with special immunoregulatory functions, further investigation of this phenomenon and its relation to possible loss of regulatory T cell function in GBS is warranted.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • CD4 Antigens / blood*
  • Female
  • Flow Cytometry / methods
  • Guillain-Barre Syndrome / immunology*
  • Guillain-Barre Syndrome / pathology
  • Humans
  • Interleukin-2 Receptor alpha Subunit / blood*
  • Lymphocyte Subsets / immunology
  • Lymphocyte Subsets / pathology*
  • Male
  • Middle Aged

Substances

  • CD4 Antigens
  • Interleukin-2 Receptor alpha Subunit